179 related articles for article (PubMed ID: 29889832)
1. Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis.
Panezai J; Ghaffar A; Altamash M; Engström PE; Larsson A
PLoS One; 2018; 13(6):e0197235. PubMed ID: 29889832
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum cytokines, chemokines, growth factors and enzymes with periodontal disease parameters.
Panezai J; Ghaffar A; Altamash M; Sundqvist KG; Engström PE; Larsson A
PLoS One; 2017; 12(11):e0188945. PubMed ID: 29190740
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
Xu S; Wang Y; Lu J; Xu J
Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of circulating inflammatory biomarkers under the influence of periodontal disease in rheumatoid arthritis patients.
Panezai J; Ali A; Ghaffar A; Benchimol D; Altamash M; Klinge B; Engström PE; Larsson A
Cytokine; 2020 Jul; 131():155117. PubMed ID: 32403006
[TBL] [Abstract][Full Text] [Related]
5. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
6. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.
Gümüş P; Buduneli E; Bıyıkoğlu B; Aksu K; Saraç F; Nile C; Lappin D; Buduneli N
J Periodontol; 2013 Nov; 84(11):1627-37. PubMed ID: 23327689
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
Skoumal M; Kolarz G; Haberhauer G; Woloszczuk W; Hawa G; Klingler A
Rheumatol Int; 2005 Nov; 26(1):63-9. PubMed ID: 15889303
[TBL] [Abstract][Full Text] [Related]
8. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
[TBL] [Abstract][Full Text] [Related]
9. [RANKL/RANK, OPG and OPT in a group of patients affected by chronic arthritis. Preliminary report].
Minenna G; D'Amore S; Maggiolini P; Scagliusi P; D'Amore M
Recenti Prog Med; 2005 Sep; 96(9):431-2. PubMed ID: 16229324
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate.
Sennels H; Sørensen S; Ostergaard M; Knudsen L; Hansen M; Skjødt H; Peters N; Colic A; Grau K; Jacobsen S
Scand J Rheumatol; 2008; 37(4):241-7. PubMed ID: 18612923
[TBL] [Abstract][Full Text] [Related]
11. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Wang XT; Li P; Xu TS; Ding R; Zhang X; Bi LQ
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):44-50. PubMed ID: 27894399
[TBL] [Abstract][Full Text] [Related]
12. The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.
Lange U; Dischereit G; Tarner I; Frommer K; Neumann E; Müller-Ladner U; Kürten B
Clin Rheumatol; 2016 Nov; 35(11):2783-2788. PubMed ID: 27053095
[TBL] [Abstract][Full Text] [Related]
13. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
D'Amore M; Fanelli M; D'Amore S; Fontana A; Minenna G
Panminerva Med; 2006 Dec; 48(4):215-21. PubMed ID: 17215793
[TBL] [Abstract][Full Text] [Related]
14. Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.
Remuzgo-Martínez S; Genre F; López-Mejías R; Ubilla B; Mijares V; Pina T; Corrales A; Blanco R; Martín J; Llorca J; González-Gay MA
Sci Rep; 2016 Jul; 6():29713. PubMed ID: 27403809
[TBL] [Abstract][Full Text] [Related]
15. Comparison of RANKL expression, inflammatory markers, and cardiovascular risk in patients with acute coronary syndrome with and without rheumatoid arthritis.
Popova V; Vazhev Z; Geneva-Popova M; Batalov A
Rheumatol Int; 2019 Oct; 39(10):1723-1732. PubMed ID: 31297563
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of RANKL/OPG, dickkopf-1 and bone marrow edema in rheumatoid arthritis with the complaint of knee pain].
Li M; Wu XH; Yin G; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):276-9. PubMed ID: 25924445
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?
Spelling P; Bonfá E; Caparbo VF; Pereira RM
Scand J Rheumatol; 2008; 37(6):439-44. PubMed ID: 18802807
[TBL] [Abstract][Full Text] [Related]
18. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
[TBL] [Abstract][Full Text] [Related]
19. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients.
Hidayat R; Isbagio H; Setyohadi B; Setiati S
Acta Med Indones; 2014 Jan; 46(1):24-9. PubMed ID: 24760805
[TBL] [Abstract][Full Text] [Related]
20. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
Geusens PP; Landewé RB; Garnero P; Chen D; Dunstan CR; Lems WF; Stinissen P; van der Heijde DM; van der Linden S; Boers M
Arthritis Rheum; 2006 Jun; 54(6):1772-7. PubMed ID: 16736519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
